Differential chemokine and chemokine receptor gene induction by ischemia, alloantigen, and gene transfer in cardiac grafts

被引:19
作者
Chen, DM
Ding, YZ
Schröppel, B
Zhang, N
Fu, S
Chen, D
Zhang, HJ
Bromberg, JS [1 ]
机构
[1] Carl C Icahn Inst Gene Therapy & Mol Med, New York, NY USA
[2] Recanati Miller Transplantat Inst, New York, NY USA
[3] Mt Sinai Sch Med, Div Nephrol, New York, NY USA
关键词
adenovirus vector; chemokine; gene transfer; transplantation;
D O I
10.1046/j.1600-6143.2003.00207.x
中图分类号
R61 [外科手术学];
学科分类号
摘要
Transplantation of allogenelic grafts presents several challenges to the innate and adaptive immune systems including chemokine leukocyte recruitment, activation, and effector function. We defined the chemokines and receptors induced by the transplant procedure/ischemia injury, alloantigen and gene transfer vector administration in murine cardiac grafts. E1 E3 deleted AdRSVPgal was transferred into grafts ai the time of transplantation, grafts were harvested after 1-14 days, and a pathway-specific cDNA array was used to evaluate the levels of 67 chemokine and chemokine receptor genes. Transplantation resulted in ischemic injury and induction of a number of similar genes in both the syngeneic and allogeneic grafts, such as CXCL1 and CXCL5, which increased dramatically on day 1 and returned rapidly to baseline in the syngeneic grafts. Alloantigen stimulated the adaptive immune response and induced the presence of more inflammatory genes within the grafts, particularly at later time points. The adenovirus vector induced a broader panel of genes, among them potent inflammatory chemokines CXCL9 and CXCL10, that are induced earlier or more strongly compared with alloantigen stimulation alone. As alloantigen and adenovirus vectors both induce similar sets of genes, targeting these molecules may not only inhibit alloimmunity, but also enhancethe utility of the genetransfer vector.
引用
收藏
页码:1216 / 1229
页数:14
相关论文
共 39 条
[1]   Adenovirus vector-induced inflammation:: Capsid-dependent induction of the C-C chemokine RANTES requires NF-κB [J].
Bowen, GP ;
Borgland, SL ;
Lam, M ;
Libermann, TA ;
Wong, NCW ;
Muruve, DA .
HUMAN GENE THERAPY, 2002, 13 (03) :367-379
[2]  
CHAVIN KD, 1993, J IMMUNOL, V151, P7249
[3]   CHEMOKINE EXPRESSION DURING HEPATIC ISCHEMIA REPERFUSION-INDUCED LUNG INJURY IN THE RAT [J].
COLLETTI, LM ;
KUNKEL, SL ;
WALZ, A ;
BURDICK, MD ;
KUNKEL, RG ;
WILKE, CA ;
STRIETER, RM .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (01) :134-141
[4]  
Colletti LM, 1996, HEPATOLOGY, V23, P506
[5]   Gene transfer of virally encoded chemokine antagonists vMIP-II and MC148 prolongs cardiac allograft survival and inhibits donor-specific immunity [J].
DeBruyne, LA ;
Li, K ;
Bishop, DK ;
Bromberg, JS .
GENE THERAPY, 2000, 7 (07) :575-582
[6]   Gene expression microarrays: a 21st century tool for directed vaccine design [J].
Dhiman, N ;
Bonilla, R ;
O'Kane, D ;
Poland, GA .
VACCINE, 2001, 20 (1-2) :22-30
[7]   Expression of chemokine genes during rejection and long-term acceptance of cardiac allografts [J].
Fairchild, RL ;
VanBuskirk, AM ;
Kondo, T ;
Wakely, ME ;
Orosz, CG .
TRANSPLANTATION, 1997, 63 (12) :1807-1812
[8]   Human gene therapy - An immature genie, but certainly out of the bottle [J].
Friedmann, T .
NATURE MEDICINE, 1996, 2 (02) :144-147
[9]   Targeting of the chemokine receptor CCR1 suppresses development of acute and chronic cardiac allograft rejection [J].
Gao, W ;
Topham, PS ;
King, JA ;
Smiley, ST ;
Csizmadia, V ;
Lu, B ;
Gerard, CJ ;
Hancock, WW .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (01) :35-44
[10]   CELLS MEDIATING ALLOGRAFT-REJECTION [J].
HALL, BM .
TRANSPLANTATION, 1991, 51 (06) :1141-1151